60 DEGREES PHARMACEUTICALS, INC. - SXTP

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q3 2026 · Compare: Q2 2026
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
Kathmere Capital Management, LLC History Added to 390,953 519 0.03% 0.02% 1 +125,853 47.47% Q3 2026 Oct 20, 2026
CITADEL ADVISORS LLC History No change 22,362 39 0.0% 0.0% 2 0 0.0% Q2 2026 Sep 02, 2026
XTX Topco Ltd History No change 17,639 31 0.0% 0.0% 3 0 0.0% Q2 2026 Aug 14, 2026
Kovack Advisors, Inc. History No change 15,000 26 0.0% 0.0% 4 0 0.0% Q2 2026 Jul 28, 2026
GEODE CAPITAL MANAGEMENT, LLC History No change 14,551 25 0.0% 0.0% 5 0 0.0% Q2 2026 Aug 12, 2026
UBS Group AG History No change 13,592 23 0.0% 0.0% 6 0 0.0% Q2 2026 Aug 13, 2026
BARCLAYS PLC History No change 1,052 1 0.0% 0.0% 7 0 0.0% Q2 2026 Aug 14, 2026
OSAIC HOLDINGS, INC. History No change 25 0 — — — 0 0.0% Q2 2026 Aug 14, 2026